CD274 and pancreatic neoplasm: With respect to pancreatic cancer, previous studies reported divergent tumoral PD-L1 levels, ranging from 12 to 90%.5,25,26 This variance in PD-L1 levels may result from the specificity of the detection methods, the quality of the samples and the quality and sensitivity of the detection antibody.